In a bid to reward shareholders, KB ... Home Builders industry’s 42.2% growth in the past year. The positive trend is solidified by the upward movement of the fiscal 2024 earnings estimates ...

KB Home Board approves $1 billion share repurchase program. KB Home Board increases dividend by 25%. Loading... Loading... KB Home KBH said its Board of Directors ...

CNBC’s Jim Cramer on Friday offered his thoughts on a range of market-moving headlines outside the Investing Club portfolio. California Schools Are in Crisis as Cafeteria Workers Leave After New ...

KB Home’s board has authorized the repurchase of up to $1 billion in shares and raised the company’s quarterly dividend to 25 cents a share from 20 cents. The Los Angeles-based homebuilder ...

LOS ANGELES - KB Home (NYSE: NYSE:KBH), a prominent homebuilder in the United States, has announced a significant increase in its quarterly cash dividend and a fresh authorization for stock ...

opens new tab beat Wall Street estimates for first-quarter profit and revenue on Thursday, riding on higher demand for its robots used in minimally invasive procedures. Investor expectations ...

LOS ANGELES - KB Home (NYSE: NYSE:KBH), a prominent homebuilder in the United States, has announced a significant increase in its quarterly cash dividend and a fresh authorization for stock ...

LOS ANGELES - KB Home (NYSE: NYSE:KBH), a prominent homebuilder in the United States, has announced a significant increase in its quarterly cash dividend and a fresh authorization for stock ...

Infosys Ltd, India's second-largest IT services company, reported a net profit of Rs 7,969 crore for the fiscal fourth quarter, beating Street estimates. The company reported revenue of Rs ...

InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates ... Earnings: Home Bancorp Beats EPS, Beats Revenue ...

London: Abbott Laboratories beat Wall Street estimates for quarterly profit on Wednesday and raised the lower end of its forecast, as robust demand for medical procedures boosted sales of its ...